HCA Healthcare (HCA) stock
NYSE
As of the Nov 13, 2026 close (U.S. Eastern)
- Market cap
- $104.3B
- As of Nov 13, 2026
- P/E
- 15.39x
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- 1.33x
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- 0.58%
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
- Market cap
- $104.3B
- As of Nov 13, 2026
- P/E
- 15.39x
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- 1.33x
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- 0.58%
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
15.39x
P/B
—
P/S
1.33x
Earnings and dividend metrics▾
Earnings
EPS
$32.42
Earnings per share
BPS
—
Book value per share
ROE
—
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $32.42 per share.
Dividends
Yield
0.58%
Dividend per share
$2.88
Payout ratio
10.0%
Consecutive years
8+ yrs
Yield uses fiscal 2025 dividends · Dividend per share and payout ratio are for fiscal 2025.
- Dividend yield — dividends divided by the share price (or market cap). It falls when the price rises.
- Dividend per share — the fiscal-year dividend per share. For one hundred shares that is about $288.00 before tax.
- Payout ratio — 10.0% of earnings was paid out as dividends.
- Consecutive years — dividends were paid every year for more than 8 years. That does not mean they will continue.
Reference only · not a promise of future dividends
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 3.6% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $19.2B+3.6%
$17.5B
Jul–Sep '24
$19.2B
Jul–Sep '25
$19.8B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Oct 29, 2026.
- Earnings per share increased 4.5% from the same quarter a year earlier.
- Revenue increased 3.6% from the same quarter a year earlier.
- Net income decreased 3.9% from the same quarter a year earlier.
Filed Oct 29, 2026 · 10-Q · SEC EDGAR
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Rossitto EricaSVP & Chief Nurse Executive · Nov 10, 2026Open-market sale3,500 shares · $1.8MAvg. price $505.810113,426 shares held after
- Foster Jon MEVP and COO · Nov 6, 2026Open-market sale21,713 shares · $10.7MAvg. price $494.947
Show 7 price lots
- 7,595 shares × $494.9145$3.8M
- 6,302 shares × $493.5795$3.1M
- 2,692 shares × $495.8541$1.3M
- 1,684 shares × $497.9984$839K
- 1,484 shares × $491.9817$730K
- 1,066 shares × $496.9199$530K
- 890 shares × $498.971$444K
- Rossitto EricaSVP & Chief Nurse Executive · Nov 6, 2026Shares withheld for taxes6,601 shares · $3.3MAvg. price $494.9916,926 shares held after
- Rossitto EricaSVP & Chief Nurse Executive · Nov 6, 2026Option exercise13,120 shares · $1.2MAvg. price $89.3356
Show 2 price lots
- 8,080 shares × $81.96$662K
- 5,040 shares × $101.16$510K
- Foster Jon MEVP and COO · Nov 4, 2026Open-market sale10,000 shares · $5.1MAvg. price $514.06980 shares held after
- Schlosser Michael JEVP and Chief Clinical Officer · Nov 4, 2026Open-market sale1,200 shares · $594KAvg. price $494.65241,443 shares held after
- Elcan Patricia F10% owner · Nov 4, 2026Other1,773,742 shares · $893.1MAvg. price $503.52532,282,889 shares held after
Show 2 price lots
- 886,871 shares × $503.525$446.6M
- 886,871 shares × $503.525$446.6M
- FRIST THOMAS F IIIDirector · Nov 4, 2026Other1,111,000 shares · $559.4MAvg. price $503.52532,282,889 shares held after
Show 2 price lots
- 555,500 shares × $503.525$279.7M
- 555,500 shares × $503.525$279.7M
- Foster Jon MEVP and COO · Nov 4, 2026Shares withheld for taxes20,309 shares · $10.4MAvg. price $510.715,571 shares held after
- Foster Jon MEVP and COO · Nov 4, 2026Other16,142 shares · $8.1MAvg. price $503.52551,453 shares held after
- Foster Jon MEVP and COO · Nov 4, 2026Option exercise35,880 shares · $5.2MAvg. price $145.2435,880 shares held after
- Marks Mike AEVP and CFO · Nov 2, 2026Other1,042 shares · $489KAvg. price $469.40525,458 shares held after
- Marks Mike AEVP and CFO · Nov 2, 2026Gift1,042 shares · $0Avg. price $02,298 shares held after
- Marks Mike AEVP and CFO · Oct 30, 2026Shares withheld for taxes2,287 shares · $1.1MAvg. price $473.192,298 shares held after
- Marks Mike AEVP and CFO · Oct 30, 2026Option exercise4,585 shares · $376KAvg. price $81.964,585 shares held after
- Schlosser Michael JEVP and Chief Clinical Officer · Oct 29, 2026Shares withheld for taxes2,455 shares · $1.2MAvg. price $478.082,643 shares held after
- Schlosser Michael JEVP and Chief Clinical Officer · Oct 29, 2026Option exercise4,928 shares · $406KAvg. price $82.3028
Show 2 price lots
- 3,030 shares × $81.96$248K
- 1,898 shares × $82.85$157K
- McAlevey Michael REVP & Chief Legal & Admin Off. · Aug 26, 2026Other7,769 shares · $3.3MAvg. price $4290 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary8-KThe company said in a press release on November 2, 2026 that its wholly owned subsidiary, HCA Inc., proposes to offer senior unsecured notes, subject to market and other considerations.Published Nov 2, 2026 · Filed Nov 2, 2026Read the summary →
- AI summary10-QThe company said revenues for Q3 2026 rose to $19.849 billion from $19.161 billion a year earlier. Net income attributable to HCA Healthcare, Inc. was $1.579 billion ($7.27 per diluted share), compared with $1.643 billion ($6.96 per share) a year earlier.Published Oct 29, 2026 · Filed Oct 29, 2026Read the summary →
- AI summary8-KHCA Healthcare said on July 29, 2026 that its subsidiary HCA Inc. increased the maximum aggregate face amount outstanding under its unsecured commercial paper program from $4.0 billion to $8.0 billion.Published Sep 30, 2026 · Filed Jul 29, 2026Read the summary →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
HCA Healthcare (HCA) stock information
NYSE
HCA Healthcare (HCA) is listed on NYSE. Its market capitalization is about $104.3B. On trailing-twelve-month earnings the P/E ratio is 15.39. These figures are computed in-house from official filings and are reference information only.
HCA Healthcare — frequently asked questions
- What is the P/E ratio of HCA Healthcare (HCA)?
- On a trailing-twelve-month basis, HCA trades at a P/E ratio of 15.39. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of HCA Healthcare?
- HCA has a market capitalization of about $104.3B. The figure moves with the share price and is refreshed each trading day.
- Does HCA Healthcare pay a dividend?
- HCA has a dividend yield of about 0.58%, based on disclosed payment history. Dividend policy can change; this is reference information only.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.